Over 235 companies worldwide claim to offer contract manufacturing services for various types of biopharmaceutical drug.

Owing to the ever-increasing number of start-ups that are involved in R&D of novel biologics, there is an enormous opportunity for the CMOs in this domain. It is worth emphasizing that, since 2000, more than 115 new CMOs have been established in order to serve to the growing demand for novel biologics that have specific manufacturing requirements. The contemporary contract services market features a mix of large and small-sized CMOs and is characterized by multiple mergers and acquisitions as stakeholders strive to broaden their respective service portfolios. This has enabled several CMOs to offer end-to-end services, ranging from drug development, including preliminary R&D, preclinical and clinical trials, to commercial scale production and regulatory filings
To order this 750+ page report, which features 200+ figures and 250+ tables, please visit this link
The USD 13.9 billion (by 2030) financial opportunity within the biopharmaceutical manufacturing market has been analyzed across the following segments:
Commonly Outsourced Business Operations
Active Pharmaceutical Ingredients (API)
Finished Dosage Formulations (FDF)
Types of Expression System
Company Size
Large and Very Large
Scale of Operation
Key Geographical Region
North America
Rest of the World
The Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030. report features the following companies, which we identified to be key players in this domain: 
3P Biopharmaceuticals
Albany Molecular Research
BioXcellence (Boehringer Ingelheim)
Charles River Laboratories
Cobra Biologics
Cytovance Biologics
GE Healthcare
Goodwin Biotechnology
Grand River Aseptic Manufacturing
IDT Biologika
KBI BioPharma
Kemwell Biopharma
LFB Biomanufacturing
Meridian Life Science
Pfizer CentreOne
Samsung BioLogics
Sanofi, CEPiA
Thermo Fisher Scientific
Vetter Pharma International
Table of Contents
1. Preface

2. Executive Summary

3. Introduction

4. Competitive Landscape

5. Biopharmaceutical Contract Manufacturing in North America

6. Biopharmaceutical Contract Manufacturing in Europe

7. Biopharmaceutical Contract Manufacturing in Asia Pacific And the Rest of The World

8. Biopharmaceutical Contract Manufacturing in Asia Pacific And the Rest of The World
9. Case Study: Outsourcing of Biosimilars

10. Case Study: Comparison of Small Molecule and   Large Molecule Drugs / Therapies
11. Case Study on In-House Manufacturing

12. Collaborations

13. Recent Developments

14. Capacity Analysis
15. Demand Analysis
16. Market Forecast
17. SWOT Analysis
18.  Future of The Biopharmaceutical CMO Market
19.  Survey Analysis
20. Interview Transcripts
21. Appendix 1: List of Non-Industry Players
22. Appendix 1: List of Non-Industry Players
23. Appendix 3: List of Companies and Organizations
To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]

You may also like


No comments yet... Be the first to leave a reply! Login here

0 Karma
242 Posts

Board header image
1 Subscribers
189 Posts

We provide market research and consulting in the pharmaceutical industry.

Made with by Mamby